Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

BFR resistance training vs BFR cycling for knee pain in athletes with patellofemoral pain

Official title: Comparative Effects of Blood Flow Restriction Resistance Training Versus Blood Flow Restriction Cycling on Pain, Quadriceps Strength, and Functional Outcomes in Athletes With Patellofemoral Pain: A Randomized Controlled Trial

Run by Ibadat International University, Islamabad · NCT07585305 · Data updated 2026-11-12

A 8-week randomized trial tests whether low-load blood flow restriction resistance training or low-resistance BFR cycling better reduces knee pain and improves leg strength and function in athletes with patellofemoral pain.

More Patello Femoral Pain Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment48 (estimated)
SponsorIbadat International University, Islamabad
Academic / other
Locations1 site (Islamabad)
StatusRecruiting
StartedMay 10, 2026
Main results expectedJuly 10, 2026
Study endsJuly 25, 2026
Registry record updatedJune 26, 2026
Trial IDNCT07585305 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Athletes aged 18-40 with clinically diagnosed patellofemoral pain syndrome and pain provoked by at least two functional activities, willing to consent, and able to participate in an 8-week program.

Probably not a fit

Individuals with recent knee surgery, significant knee injuries, contraindications to BFR, or pregnancy may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind trial compares two blood flow restriction (BFR) training modalities in 60 athletes aged 18-40 with patellofemoral pain syndrome. Group A performs BFR resistance training (leg press and seated knee extension at 30% 1RM) 3 times weekly, while Group B does BFR cycling with low resistance under similar supervision. Both groups receive limb occlusion at 80% of limb occlusion pressure during sessions over 8 weeks, with outcomes measured at baseline and week 8, including pain (NPRS), quadriceps strength, and Kujala knee function. Data will be analyzed using appropriate within- and between-group tests to determine differences in pain, strength, and functional outcomes. The study aims to determine if one BFR modality offers superior symptom relief or functional gains for athletes with PFP.

Why it matters

Potential benefit: If successful, the trial could identify a more tolerable or more effective BFR approach to improve pain and function in athletes with patellofemoral pain.

How similar studies have gone: Prior BFR research supports gains at low loads for strength, but direct comparisons of BFR modalities in patellofemoral pain are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male and female athletes aged 18-40 years
2. Clinically diagnosed with patellofemoral pain syndrome
3. Anterior or retropatellar knee pain of at least 3 months duration
4. Pain provoked by at least two functional activities (e.g., squatting, stair climbing, running, prolonged sitting)
5. Willingness to participate and provide written informed consent

Exclusion Criteria:

1. History of knee surgery or significant knee trauma in the past 6 months
2. Presence of ligament, meniscal, or cartilage injuries
3. Neurological, vascular, or systemic inflammatory conditions
4. Contraindications to BFR training (e.g., deep vein thrombosis, uncontrolled hypertension)
5. Pregnancy

Where it's running

  • Ibadat International University, Islamabad (Iiui)
    Islamabad, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Hafsah Gul Khattak, DPT, MS-NMPT — Ibadat International University, Islamabad (Iiui)
  • Study coordinator: Haroon Khan, MS. Sports Physical Therapy
  • Email: haroonkhan2k00@gmail.com
  • Phone: +923000526711

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.